期刊
CELL REPORTS
卷 14, 期 9, 页码 2154-2165出版社
CELL PRESS
DOI: 10.1016/j.celrep.2016.02.004
关键词
-
类别
资金
- NIH [R21CA179720, R21CA173150, R21CA179720S1, R21CA179720S2, U54-CA149196]
- DOD [DAMD W81XWH-11-1-0292]
- DLDCC Pilot Projects
- BCM Cancer Center Grant [P30CA125123]
- DEF [NIH-R01CA184208]
- MTL [P50CA50183, R01CA112305, U54 CA149196, P01CA30195]
- AS [R21CA185516, U01CA179674]
- NP [ACS 127430-RSG-15-105-01-CNE]
- CPRIT Proteomics and Metabolomics Core Facility [RP120092]
- Cytometry and Cell Sorting Core [NIAID P30AI036211, NCRR S10RR024574]
Transmitochondrial cybrids and multiple OMICs approaches were used to understand mitochondrial reprogramming and mitochondria-regulated cancer pathways in triple-negative breast cancer (TNBC). Analysis of cybrids and established breast cancer (BC) cell lines showed that metastatic TNBC maintains high levels of ATP through fatty acid beta oxidation (FAO) and activates Src oncoprotein through autophosphorylation at Y419. Manipulation of FAO including the knocking down of carnitine palmitoyltransferase-1A (CPT1) and 2 (CPT2), the rate-limiting proteins of FAO, and analysis of patient-derived xenograft models confirmed the role of mitochondrial FAO in Src activation and metastasis. Analysis of TCGA and other independent BC clinical data further reaffirmed the role of mitochondrial FAO and CPT genes in Src regulation and their significance in BC metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据